The Alliance for Biomedical Research in Europe (BioMed Alliance) is a unique initiative representing 21 leading research-oriented medical societies that include more than 200.000 researchers across Europe.
The mission of the BioMed Alliance is to advance and strengthen biomedical research, in particular translational research, which is crucial for innovation.
For more information on the Alliance please visit www.biomedeurope.org
ECCO- the European CanCer Organisation is a founding member of the Alliance for Biomedical Research in Europe (BioMed Alliance), together with the European Association for the Study of Diabetes (EASD), European Respiratory Society (ERS) and the European Society of Cardiology (ESC).
The BioMed Alliance aims at promoting the best interests and values of research across all medical disciplines in Europe, in those general areas where common interest is identified.
As a result of the current legislative discussions on the next research framework programme, Horizon 2020, the BioMed Alliance has focused its activities on advocating for a strategic instrument – the ‘European Council for Health Research (EuCHR)’ to foster innovation in Europe by using contemporary evidence to bridge the gap between health research and policy for the benefit of society. A scientific-led strategic body that can steer research and innovation across the entire health spectrum lies at the core of the EuCHR concept. A ‘Concept Paper’ to develop this proposal has been created, as well as a proposal for the implementation of a ‘Scientific Steering Board’.
ECCO has actively contributed to the activities of the BioMed Alliance. ECCO Board Member and Policy Committee Chair Prof. Julio Celis is Vice-President of the Alliance and ECCO President-Elect, Prof. Martine Piccart is a member of the Core Working Group, a group of science policy experts who provided important input to development of the EuCHR concept.
In May 2012, a joint meeting was co-organised by the European Commission and BioMed Alliance in the Belgian Royal Academy of Medicine in Brussels to discuss ‘The Future of Health Research and Innovation in Europe: The need for strategic action’, as part of the discussions on Horizon 2020.
The objectives of the BioMed Alliance include to:
- facilitate and improve biomedical research in Europe
- develop a framework for better training and mobility of young researchers in Europe
- improve public understanding of medical science in Europe
Through its actions, the Alliance intends to:
- promote excellence in European biomedical research
- advocate for increased funding in favour of biomedical research
BioMed Alliance Executive Committee
- Prof. Ulf Smith, President, representing EASD (2009-2012)
- Prof. Julio Celis, Vice President, representing ECCO (2009-2012)
- Prof. Karin Sipido, Vice President, representing ESC (2009-2012)
- Prof. Laurent Nicod, Treasurer, representing ERS (2009-2012)
PRINT THIS PAGE
Page last modified: